The prognostic relevance of interactions between venous invasion, lymph node involvement and distant metastases in renal cell carcinoma after radical nephrectomy

BMC Urology

Volumn 8, Issue 1, 2008, Pages

  Zubac, Dragomir P ^a   Bostad, Leif ^b   Seidal, Tomas ^c   Wentzel Larsen, Tore ^b   Haukaas, Svein A ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c CENTRAL HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CAVA VEIN; COMPUTER ASSISTED TOMOGRAPHY; DISTANT METASTASIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICAL RECORD REVIEW; NEPHRECTOMY; PROGNOSIS; RETROSPECTIVE STUDY; TUMOR VOLUME; AGED; CANCER INVASION; CANCER STAGING; COMPARATIVE STUDY; KIDNEY TUMOR; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; SURVIVAL RATE; VASCULAR TUMOR;

AGED; CARCINOMA, RENAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEPHRECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; VASCULAR NEOPLASMS;

EID: 59449108835     PISSN: 14712490     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/1471-2490-8-19     Document Type: Article

References (28)

1. Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy. AJ Pantuck A Zisman F Dorey DH Chao K Han J Said BJ Gitlitz AS Belldegrun RA Figlin, Cancer 2003 97 2995 3002 10.1002/cncr.11422 12784334
2. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical neophrectomi based on tumour stage, size, grade and necrosis: The SSIGN score. I Frank ML Blute JC Cheville CM Lohse AL Weaver H Zincke, J Urol 2002 168 2395 400 10.1016/S0022-5347(05)64153-5 12441925
3. ECOG performance status 0 or 1 and symptom classification do not improve the ability to predict renal cell carcinoma-specific survival. PI Karakiewicz Q-D Trinh A Taille CC Abbou L Salomon J Tostain L Cindolo W Artibani V Ficarra JJ Patard, Euro J Cancer 2007 43 1023 1029 10.1016/j.ejca.2007.01.020
4. The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma. S Sengupta CM Lohse JC Cheville BC Leibovich RH Thompson WS Webster I Frank H Zincke M Blute ED Kwon, Cancer 2005 106 304 12 10.1002/cncr.21617
5. Radical extensive surgery for renal cell carcinoma: Long term results and prognostic factors. L Giuliani C Giberti G Martorana S Rovida, J Urol 1990 143 468 74 2304155
6. Vein invasion in renal cell carcinoma: impact on metastatic behaviour and survival. B Ljungberg R Stenling B Osterdahl E Farrelly T Åberg G Roos, J Urol 1995 154 1681 4 10.1016/S0022-5347(01)66749-1 7563321
7. Radical nephrectomy for renal cell carcinoma: long-term results and prognostic factors on a series of 328 cases. C Giberti F Oneto G Martorana S Rovida G Carmignani, Eur Urol 1997 31 1 40 48 9032533
8. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. ML Blute BC Leibovich CM Lohse JC Cheville H Zincke, BJU Int 2004 94 33 41 10.1111/j.1464-410X.2004.04897.x 15217427
9. Redefining pT3 renal cell carcinoma in the modern era. A proposal for a revision of the current TNM primary tumor classification system. V Margulius P Tamboli SF Matin M Meisner DA Swanson CG Wood, Cancer 2007 109 2439 44 10.1002/cncr.22713 17487856
10. Reassessing the current TNM lymph node staging for renal cell carcinoma. C Terrone C Cracco F Porpiglia E Bollito C Scoffone M Poggio A Berruti F Ragni M Cossu RM Scarpa SR Rossetti, Eur Urol 2006 49 2 324 331 10.1016/j.eururo.2005. 11.014 16386352
11. The influence of pNx/pN0 grouping in a multivariate setting for outcome modelling in patients with clear cell renal cell carcinoma. JF Ward ML Blute JC Cheville CM Lohse AL Weaver Z Horst, J Urol 2002 168 56 60 10.1016/S0022- 5347(05)64831-8 12050492
12. Renal cell carcinoma: A clinicopathological follow-up study after radical nephrectomy. DP Zubac L Bostad C Gestblom B Kihl T Seidal T Wentzel-Larsen AM Bakke, Scand J Urol Nephrol 2007 41 3 191 7 10.1080/00365590601016552 17469026
13. th edition. FL Greene DL Page ID Fleming A Fritz CM Balch DG Haller, New York: Springer-Verlag 2002 323 8
14. Toxicity and response criteria of the Eastern Cooperative Oncology Group. NM Oken RH Creech DC Tormey J Horton TE Davis ET McFadden PP Carbone, Am J Clin Oncol 1982 5 6 649 55 10.1097/00000421-198212000-00014 7165009
15. National Committee for Clinical Laboratory Standards. Reference and selected procedure for erythrocyte sedimentation rate (ESR) test; approved standard-fourth edition. JA Koepke BS Bull E Simson OW van Assendelft, Wane, Pennsylvania, USA 2000 20 27
16. Erythrocyte sedimentation rate. Use of fresh blood for quality controll. M Plebani E Piva, Am J Clin Pathol 2002 117 621 626 10.1309/QB1G-6FRR-DNWX-BKQ9 11939738
17. The Heidelberg classification of renal cell tumours. G Kovacs M Akhtar BJ Beckwith P Bugert CS Cooper B Delahunt JN Eble S Fleming B Ljungberg J Medeiros H Moch VE Reuter E Ritz G Roos D Schmidt JR Srigley S Störkel E Van Der Berg B Zbar, J Pathol 1997 183 131 3 10.1002/(SICI)1096-9896(199710)183: 2<131::AID-PATH931>3.0.CO;2-G 9390023
18. Renal cell carcinoma: prognostic significance of incidentally detected tumours. K Tsui O Shvarts RB Smith R Figlin DB Dekernion A Belldegrun, J Urol 2000 163 426 430 10.1016/S0022-5347(05)67892-5 10647646
19. Incidentally detected renal cell carcinoma: pathological features, survival trends and implications for treatment. JP Sweeney JA Thornhill R Grainger TED McDermott MR Butler, Br J Urol 1996 78 351 353 8881940
20. Clinicopathological features of recurrence after radical surgery for non-metstatic renal cell carcinoma. T Ishimura I Sakai K Harada I Hara H Eto H Miyake, Int J Clin Oncol 2004 9 369 372 10.1007/s10147-004-0409-1 15549586
21. Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients. T Gudbjartsson A Thoroddsen V Petursdottir G Hardarson J Magnusson GV Einarsson, Urology 2005 66 1186 1191 10.1016/j.urology.2005.07.009 16360438
22. Predictive values of acute phase reactants, basic fetoprotein, and immunosuppressive acidic protein for staging and survival in renal cell carcinoma. Y Miyata S Koga M Nishikido M Nishikido S Kanda T Hayashi Y Saito H Kanetake, Urology 2001 58 161 164 10.1016/S0090-4295(01)01165-7 11489689
23. Renal cell carcinoma with tumour thrombus extension: biology, role of nephrectomy and response to immunotherapy. A Zisman JA Wieder AJ Pantuck DH Chao F Dorey JW Said BJ Gitlitz JB deKernion RA Figlin AS Belldegrun, J Urol 2003 169 3 909 16 10.1097/01.ju.0000045706.35470.1e 12576811
24. Surgical management of renal cell carcinoma with inferior vena cava tumour thrombus. JC Nesbitt ER Soltero CPN Dinney GL Walsh DS Schrump DA Swanson LL Pisters KD Willis JB Putnam, Ann Thorac Surg 1997 63 1592 600 10.1016/S0003-4975(97)00329-9 9205155
25. Renal cell carcinoma with the extension of tumour thrombus into the vena cava: Surgical strategy and prognosis. Y Tsuji A Goto I Hara K Ataka C Yamashita Y Okita S Kamidono, J Vasc Surg 2001 33 789 96 10.1067/mva.2001.111996 11296333
26. Radical nephrectomy with and without lymph node dissection: preliminary results of the EORTC randomiced phase III protocol 30881. EORTC Genitourinary Group. JH Blom H van Poppel JM Marrechal D Jacqmin R Sylvester FH Schroder L de Prijck, Eur Urol 1999 36 6 570 5 10.1159/000020050 10559610
27. Lymphatogenous spread of renal cell carcinoma: An autopsy study. JA Johnsen S Hellsten, J Urol Oxford: isis Medical Media, Donohue JP, 1995 157 2 31 34 8996329
28. Renal cell carcinoma with nodal metastases in the absence of distant metastases (clinical stage TxN1/2M0): the impact of aggressive surgical resection on patient outcome. SE Canfield AM Kamat RF Sanchez-Oritiz M Detry DA Swanson CG Wood, J Urol 2006 175 864 9 10.1016/S0022-5347(05)00334-4 16469567